Alvotech (ALVO) Profit After Tax (2021 - 2026)
Alvotech's (ALVO) quarterly Profit After Tax came in at $79000.0 in Q1 2026, up 100.04% YoY from $39492.9 in Q1 2025, and down 99.96% on a QoQ basis from $192.8 million in Q4 2025.
Alvotech (ALVO) Profit After Tax (2021 - 2026) Analysis & Trends
Alvotech (ALVO) has 6 years of Profit After Tax data on file, last reported at $79000.0 in Q1 2026.
- Quarterly Profit After Tax rose 100.04% year-over-year to $79000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $246.7 million (up 140.1% YoY) and the FY2025 annual result came in at $27.9 million, up 112.04% from the prior year.
- Profit After Tax slipped to $79000.0 in Q1 2026, from $192.8 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $360.4 million in Q2 2025 to a low of -$551.7 million in Q4 2023.
- A 5-year average of -$116.3 million and a median of -$86.9 million in 2023 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2024 — Profit After Tax jumped 277.55% — and 2025, when it sank 99900.0%.
- Tracing ALVO's Profit After Tax over 5 years: stood at -$513.6 million in 2022, then retreated by 7.43% to -$551.7 million in 2023, then jumped by 57.98% to -$231.9 million in 2024, then jumped by 183.16% to $192.8 million in 2025, then sank by 99.96% to $79000.0 in 2026.
- The last three Profit After Tax figures came in at $79000.0 (Q1 2026), $192.8 million (Q4 2025), and -$306.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.65 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.45 Bn | 29.77 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | 710.56 Mn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Alvotech | 1.23 Bn | 1.23 Bn | 5.09 Mn | 79,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 79,000.00 |
| Dec 31, 2025 | 192.82 Mn |
| Sep 30, 2025 | -306.62 Mn |
| Jun 30, 2025 | 360.45 Mn |
| Mar 31, 2025 | -218.73 Mn |
| Dec 31, 2024 | -231.86 Mn |
| Sep 30, 2024 | -318.40 Mn |
| Jun 30, 2024 | 153.72 Mn |
| Mar 31, 2024 | -218,729.00 |
| Dec 31, 2023 | -551.73 Mn |
| Aug 31, 2023 | -86.85 Mn |
| Jun 30, 2023 | -86.58 Mn |
| Mar 31, 2023 | -276,180.00 |
| Dec 31, 2022 | -513.58 Mn |
| Aug 31, 2022 | -184.47 Mn |
| Jun 30, 2022 | -107.49 Mn |
| Mar 31, 2022 | -76.98 Mn |
| Dec 31, 2021 | 253.76 Mn |
| Sep 30, 2021 | -81.32 Mn |